advertisement
Abstract #8962 Published in IGR 5-2
Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma
Azevedo H; Ciarniello MG; Rosignoli MT; Dionisio P; Cunha-Vaz JEuropean Journal of Ophthalmology 2003; 13: 370-376
PURPOSE: On the basis of intraocular pressure (IOP) measurements and fluorophotometry, the authors assessed the effects of 2% ibopamine eye drops on aqueous humor production in normal and glaucomatous eyes. METHODS: Thirty subjects (15 healthy volunteers and 15 open-angle glaucoma patients with ocular hypertension) were included in a placebo-controlled study with random assignment of treatment from masked containers. All subjects underwent ophthalmological examination and IOP measurements. Fluorophotometry was performed in both eyes at baseline (without treatment) and during treatment. Each subject was treated with one drop of 2% ibopamine in one eye and one drop of placebo in the fellow eye 30 minutes before fluorophotometric scans, and every hour after the first instillation (for a total of four times). Safety was evaluated by recording adverse events and ocular symptoms and signs. Aqueous humor flow data were analyzed using the paired t-test, comparing ibopamine and placebo-treated eyes. RESULTS: No changes in IOP were detected in normal eyes, whereas glaucomatous eyes showed a mean increase of 4 mmHg (95% CI 3.46-4.51) from baseline. The difference in IOP between healthy eyes and those with glaucoma was significant (p < 0.0001). In normal eyes and patients with glaucoma, ibopamine led to a significant increase in aqueous humor flow compared to placebo-treated eyes (p < 0.01). The safety profile of ibopamine was very good. CONCLUSIONS: These results seem to confirm that ibopamine increases aqueous humor production in normal and glaucomatous eyes, raising IOP only in eyes with glaucoma.
Dr. H. Azevedo, AIBILI, Clinical Trial Centre, Azinhaga St. Comba, Celas, Coimbra, Portugal
Classification:
11.3.5 Other (Part of: 11 Medical treatment > 11.3 Adrenergic drugs)
